Amylyx Pharmaceuticals
AMLX
#5441
Rank
HK$11.09 B
Marketcap
HK$99.80
Share price
-0.93%
Change (1 day)
137.84%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of HK$0.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2025

Annual revenue

Year Revenue Change
2025 N/A-100%
2024 HK$0.67 B-77.19%
2023 HK$2.97 B1612.24%
2022 HK$0.17 B
2021 N/A